Living Cell Technologies Limited [ASX:LCT] share price and news 2022

Company Description

Living Cell Technologies (LCT) develops cell therapies to treat diseases with high unmet clinical needs. The Australasian biotechnology company is a global pioneer in the field of cell encapsulation and implantation for human therapeutics.

Living Cell Technologies Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.lctglobal.com.

This a small cap company with market cap of 8 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 3 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how lct dividend grows in the recent years.

No data